Prescription trends for preservative free glaucoma medication in a public health system

Eur J Ophthalmol. 2024 Jan;34(1):193-203. doi: 10.1177/11206721231170034. Epub 2023 Apr 17.

Abstract

Purpose: To analyze the prescribing trends over a 7-years period, between 2013 and 2020, in a tertiary hospital (Hospital Clinico San Carlos, Madrid, Spain) and its health area.

Material and methods: A retrospective study on the data collected from the information systems, "farm@web" and "Farmadrid", of glaucoma prescriptions in the framework of a public health system (Spanish National Health System) during the last seven years.

Results: Prostaglandin analogues were the most commonly used drugs in monotherapy during the study period (range: 36.82% - 47.07%). Fixed combinations of topical hypotensives had an upward trend since 2013 (range: 39.99% - 54.21%), becoming the most dispensed drugs in 2020 (48.99%). Preservative-free eye drops (lacking benzalkonium chloride, BAK) have displaced preservative containing topical treatments in all pharmacological groups. In 2013, BAK-preserved eye drops accounted for 91.1% of the total prescriptions, however in 2020 they only accounted for 34.2% of total prescriptions.

Conclusions: The results of the present study highlight the current trend to avoid BAK-preserved eye drops for the treatment of glaucoma.

Keywords: CORNEA / EXTERNAL DISEASE; GLAUCOMA; Glaucoma medical therapies; epidemiology / risk factors; health economics; ocular surface agents; open angle glaucoma.

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Benzalkonium Compounds
  • Glaucoma* / drug therapy
  • Glaucoma, Open-Angle* / drug therapy
  • Humans
  • Intraocular Pressure
  • Ocular Hypertension* / drug therapy
  • Ophthalmic Solutions / therapeutic use
  • Prescriptions
  • Preservatives, Pharmaceutical / therapeutic use
  • Public Health
  • Retrospective Studies

Substances

  • Preservatives, Pharmaceutical
  • Antihypertensive Agents
  • Benzalkonium Compounds
  • Ophthalmic Solutions